FDA Urges Limited Use of Pfizer's Celebrex, Bextra
196813
U.S. health officials on Thursday  called on doctors to limit prescribing Pfizer Inc. painkillers  Celebrex and Bextra in light of recent evidence that they may  increase the risk of heart attack and stroke.
122874
Pfizer (PFE) said Friday that it has received new information about the cardiovascular safety of its popular arthritis drug Celebrex, based on an analysis of a long-term cancer trial, but it has no plans to withdraw the drug.
692821
The arthritis drug Bextra will begin carrying a warning on the label about possible heart and blood-clotting problems, the Food and Drug Administration said yesterday.
238122
The Food and Drug Administration yesterday called for an evaluation of all prevention studies involving two controversial painkillers - Celebrex and Bextra - to ensure adequate protection for participants who use the pills.
116025
WASHINGTON The Food and Drug Administration has ordered a sweeping review of studies involving prescription painkillers like Celebrex and Bextra.
224819
The U.S. Food and Drug Administration has warned Pfizer Inc.  that television and print advertisements for its painkillers Celebrex and Bextra misled consumers, according to a letter made public on Wednesday.
211731
The Food and Drug Administration on Thursday ordered a review of all prevention studies involving drugs such as Celebrex and Bextra, which have been associated with increased risk of heart problems. The agency also urged the public to limit use of over-the-counter pain medications.
352014
Pfizer Inc. will warn doctors that its Bextra painkiller, which is in the same group of drugs as Merck &amp; Co.&#39;s withdrawn Vioxx, is linked to an elevated risk of blood clots, heart attacks and strokes in cardiac-surgery patients.
102866
A study suggesting arthritis drug Bextra doubles patients&#39; heart attack and stroke risks drew a sharp rebuttal Wednesday from the drug&#39;s maker, Pfizer (PFE), as its stock price dipped.
562722
Pfizer Inc.&#39;s Bextra will come with a new warning about possible heart and blood clotting problems when the drug is used by patients who have just had heart bypass surgery, the US Food and Drug Administration said on Thursday.
223110
The Food and Drug Administration has published a note on its Web site regarding new warnings added to the labeling for Bextra, an arthritis pain drug made by Pfizer (nyse: PFE - news - people ). The warnings
259938
NEW YORK, October 15  - Pfizer Inc (PFE.NYS) plans to conduct an additional cardiovascular safety review of its arthritis painkiller, Bextra.
683158
CelebrexÂ®, VIOXXÂ®, and BextraÂ®, products of, respectively, Pfizer, Merck, and Pfizer, are COX-2 inhibitors, meaning that they suppress the expression of the COX-2 enzyme that is normally
181893
The U.S. Food and Drug  Administration on Thursday ordered the review of preventative  studies involving Pfizer Inc.'s painkillers Celebrex and  Bextra, in light of recent evidence they may increase the risk  of heart attack and stroke.
66408
NEW YORK - On. Dec. 17, the US Food and Drug Administration released a statement relating to Pfizer&#39;s (nyse: PFE - news - people ) Celebrex.
729940
NEW YORK, OCTOBER 15 : PFIZER Inc. on Friday said two clinical trials showed patients taking its anti-inflammatory drug Bextra, had a higher risk of cardio-vascular events during high-risk coronary bypass surgery.
84533
Pfizer Inc. PFE.N on Friday said two  clinical trials showed patients taking its anti-inflammatory  drug Bextra had a higher risk of cardiovascular events during  high-risk coronary bypass surgery.